Virtual colonoscopy finds anomalies outside the colon that require additional tests though they often present no risk to patients. These tests unnecessarily raise the overall cost of healthcare, making CT colonography more expensive than the traditional procedure, according to a study conducted by Dr. Richard S. Bloomfeld, an assistant professor of medicine at Wake Forest University Baptist Medical Center.
Virtual colonoscopy finds anomalies outside the colon that require additional tests though they often present no risk to patients. These tests unnecessarily raise the overall cost of healthcare, making CT colonography more expensive than the traditional procedure, according to a study conducted by Dr. Richard S. Bloomfeld, an assistant professor of medicine at Wake Forest University Baptist Medical Center.
Bloomfeld presented the study results at the American College of Gastroenterology meeting in Las Vegas on Oct. 25. While acknowledging that CTC will play a future role in colon cancer screening, Bloomfeld, a gastroenterologist, argues that its time has not yet come.
"It is important to understand the implications of findings outside the colon before we advocate widespread use of this technology," he said.
CTC is intended to detect small growths or polyps so that, if found, they can be removed through a conventional optical endoscope. Research scheduled to be published in the November issue of Radiology supports the conclusion that virtual colonoscopy is as effective as optical endoscopy, when screening for colorectal cancer (DI SCAN, 10/19/06, Virtual colonoscopy offers alternative to endoscopy). The University of Wisconsin-Madison researchers conclude that, because of its increased ease and relative patient comfort, CTC holds the potential to improve compliance for colorectal cancer prevention and screening.
The Wake Forest physicians acknowledge that CTC is better able to see polyps than barium enemas and is nearly as accurate as conventional colonoscopy, noting that most patients report CTC is more comfortable than either procedure. The problem comes when the CT exam results in findings beyond its intended area of application.
Wake Forest study findings outside the colon, such as lung nodules and indeterminate kidney lesions, led to additional testing. This added about $231 to each CTC exam performed during colorectal cancer screening of average risk patients. Bloomfeld and colleagues reported that the suspicious findings discovered outside the colon were often benign.
"Finding things outside the colon on a virtual colonoscopy can be a good thing or a bad thing," he said. "It's a good thing if we find unknown conditions that are treated, but a bad thing if we put people through more invasive tests with risks and additional costs for no reason."
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.